AF
GNOM icon

Advisornet Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Advisornet Financial’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38
Closed -$1.71K – 2063
2024
Q3 		$1.71K Hold
38
– – ﹤0.01% 1790
2024
Q2 		$1.59K Hold
38
– – ﹤0.01% 1682
2024
Q1 		$1.73K Hold
38
– – ﹤0.01% 1622
2023
Q4 		$1.76K Hold
38
– – ﹤0.01% 1746
2023
Q3 		$1.55K Hold
38
– – ﹤0.01% 1707
2023
Q2 		$1.84K Hold
38
– – ﹤0.01% 1741
2023
Q1 		$1.87K Buy
+38
New +$1.96K ﹤0.01% 1725

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Advisornet Financial's GNOM Position: Q4 2024 in Review

Advisornet Financial sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2024, closing a stake of 38 shares — an estimated $1.71K sold.

Advisornet Financial first reported a position in GNOM in Q1 2023 and held it in 7 quarters. The position peaked at $1.87K in Q1 2023. 68 funds tracked by Wall St. Rank hold GNOM as of Q4 2024.

  • Advisornet Financial reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Advisornet Financial sold 38 Global X Genomics & Biotechnology ETF shares in Q4 2024, an estimated $1.71K.
  • Advisornet Financial first reported a position in Global X Genomics & Biotechnology ETF in Q1 2023 and held it in 7 quarters.
  • Advisornet Financial's Global X Genomics & Biotechnology ETF position peaked at $1.87K in Q1 2023.
  • 68 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.